Clinical Trial Update: A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine plus paclitaxel and gemcitabine plus docetaxel in metastatic breast cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Neoplasms | Phase 2 | Status: COMPLETED